Coronavirus Treatment Trial
- All
- News
- Videos
-
Nasal Spray That Fights Covid? You Might Already Have It At Home
- Friday September 12, 2025
- Science | Edited by Nikhil Pandey
In addition to showing a marked reduction in coronavirus infections, the azelastine group also displayed fewer symptomatic SARS-CoV-2 infections.
-
www.ndtv.com
-
AstraZeneca Claims Positive Medicine Trial For "Severe" Covid
- Wednesday June 8, 2022
- World News | Agence France-Presse
A treatment for people at risk of death from coronavirus has revealed good results in a late-stage trial, its maker AstraZeneca announced Wednesday.
-
www.ndtv.com
-
Pfizer Says Its Antiviral Pill Cuts Risk Of Severe Covid By 89%
- Friday November 5, 2021
- World News | Reuters
A trial of Pfizer Inc's experimental antiviral pill for COVID-19 was stopped early after the drug was shown to cut by 89% the chances of hospitalization or death for adults at risk of developing severe disease.
-
www.ndtv.com
-
WHO-Led Trial To Study 3 Anti-Inflammatory Drugs For Covid Patients
- Wednesday August 11, 2021
- World News | Reuters
The World Health Organization (WHO) said on Wednesday a clinical trial in 52 countries would study three anti-inflammatory drugs as potential treatments for COVID-19 patients.
-
www.ndtv.com
-
Cambridge University Researchers Use AI to Find 200 Drugs For COVID Treatment
- Friday July 2, 2021
- Edited by Gadgets 360 Newsdesk
Researchers at Cambridge University combined computational biology and machine learning to study proteins linked to COVID-19, and then studied 2,000 drugs to find suitable treatments, coming up with a list of 200 possibilities.
-
www.gadgets360.com
-
Covid Positive Haryana Home Minister Anil Vij Stable, Likely To Be Discharged Soon
- Monday December 28, 2020
- India News | ANI
Haryana Home and Health Minister Anil Vij, who has been undergoing treatment for Covid at a Gurugram hospital since December 15, is likely to be discharged in the next few days as doctors attending to him are satisfied with the progress in his health.
-
www.ndtv.com
-
Dr. Reddy's Shuts Key Plans, Isolates Data Centre Services After Cyberattack
- Thursday October 22, 2020
- Gadgets 360 Staff With Inputs From Reuters
Pharmaceutical giant Dr. Reddy's Laboratories today said that it had isolated all its data centre services as a preventive measure following a cyberattack. The drug maker had shut its key plants globally due to the breach at its servers, ET Now had reported, citing sources.
-
www.gadgets360.com
-
US Pharma Firm Lilly Pauses COVID Antibody Treatment Trial Over Safety Concern
- Wednesday October 14, 2020
- World News | Agence France-Presse
US pharmaceutical firm Eli Lilly on Tuesday paused a late-stage trial of its experimental lab-produced antibody treatment against Covid-19 over an unspecified safety concern, the company said.
-
www.ndtv.com
-
"Antisera" With Potential To Treat Covid Gets Nod For Phase-1 Human Trials
- Wednesday October 7, 2020
- India News | Press Trust of India
The Drugs Controller General of India has given permission for conducting Phase-1 human clinical trial for an "antisera" that was developed by injecting inactivated SARS-CoV-2 in horses and can be a potential treatment for COVID-19, ICMR officials said on Tuesday.
-
www.ndtv.com
-
HIV Treatment Has No Benefit For Hospitalised COVID-19 Patients: Study
- Tuesday October 6, 2020
- World News | Reuters
A combination of antiviral drugs usually used to treat HIV has no beneficial effect in patients hospitalised with COVID-19, a peer-reviewed study said on Monday, confirming the initial results of a large-scale randomised trial of the drug.
-
www.ndtv.com
-
Nasal Spray That Fights Covid? You Might Already Have It At Home
- Friday September 12, 2025
- Science | Edited by Nikhil Pandey
In addition to showing a marked reduction in coronavirus infections, the azelastine group also displayed fewer symptomatic SARS-CoV-2 infections.
-
www.ndtv.com
-
AstraZeneca Claims Positive Medicine Trial For "Severe" Covid
- Wednesday June 8, 2022
- World News | Agence France-Presse
A treatment for people at risk of death from coronavirus has revealed good results in a late-stage trial, its maker AstraZeneca announced Wednesday.
-
www.ndtv.com
-
Pfizer Says Its Antiviral Pill Cuts Risk Of Severe Covid By 89%
- Friday November 5, 2021
- World News | Reuters
A trial of Pfizer Inc's experimental antiviral pill for COVID-19 was stopped early after the drug was shown to cut by 89% the chances of hospitalization or death for adults at risk of developing severe disease.
-
www.ndtv.com
-
WHO-Led Trial To Study 3 Anti-Inflammatory Drugs For Covid Patients
- Wednesday August 11, 2021
- World News | Reuters
The World Health Organization (WHO) said on Wednesday a clinical trial in 52 countries would study three anti-inflammatory drugs as potential treatments for COVID-19 patients.
-
www.ndtv.com
-
Cambridge University Researchers Use AI to Find 200 Drugs For COVID Treatment
- Friday July 2, 2021
- Edited by Gadgets 360 Newsdesk
Researchers at Cambridge University combined computational biology and machine learning to study proteins linked to COVID-19, and then studied 2,000 drugs to find suitable treatments, coming up with a list of 200 possibilities.
-
www.gadgets360.com
-
Covid Positive Haryana Home Minister Anil Vij Stable, Likely To Be Discharged Soon
- Monday December 28, 2020
- India News | ANI
Haryana Home and Health Minister Anil Vij, who has been undergoing treatment for Covid at a Gurugram hospital since December 15, is likely to be discharged in the next few days as doctors attending to him are satisfied with the progress in his health.
-
www.ndtv.com
-
Dr. Reddy's Shuts Key Plans, Isolates Data Centre Services After Cyberattack
- Thursday October 22, 2020
- Gadgets 360 Staff With Inputs From Reuters
Pharmaceutical giant Dr. Reddy's Laboratories today said that it had isolated all its data centre services as a preventive measure following a cyberattack. The drug maker had shut its key plants globally due to the breach at its servers, ET Now had reported, citing sources.
-
www.gadgets360.com
-
US Pharma Firm Lilly Pauses COVID Antibody Treatment Trial Over Safety Concern
- Wednesday October 14, 2020
- World News | Agence France-Presse
US pharmaceutical firm Eli Lilly on Tuesday paused a late-stage trial of its experimental lab-produced antibody treatment against Covid-19 over an unspecified safety concern, the company said.
-
www.ndtv.com
-
"Antisera" With Potential To Treat Covid Gets Nod For Phase-1 Human Trials
- Wednesday October 7, 2020
- India News | Press Trust of India
The Drugs Controller General of India has given permission for conducting Phase-1 human clinical trial for an "antisera" that was developed by injecting inactivated SARS-CoV-2 in horses and can be a potential treatment for COVID-19, ICMR officials said on Tuesday.
-
www.ndtv.com
-
HIV Treatment Has No Benefit For Hospitalised COVID-19 Patients: Study
- Tuesday October 6, 2020
- World News | Reuters
A combination of antiviral drugs usually used to treat HIV has no beneficial effect in patients hospitalised with COVID-19, a peer-reviewed study said on Monday, confirming the initial results of a large-scale randomised trial of the drug.
-
www.ndtv.com